ALAMEDA, Calif., March 21, 2018 /PRNewswire/ -- Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singulex cTnI assay and Single Molecule Counting technology ...

Increased levels of plasma troponin I on a high-sensitivity assay are associated with an increased risk of cardiovascular events, particularly hospitalizations for heart failure, in a community-based ...

Background Marathon running has numerous cardiovascular effects. Studies report transient physiological changes, while others ...

NORTHBROOK, Ill., Dec. 17, 2010 (GLOBE NEWSWIRE) -- A clinical study released online by the European Journal of Heart Failure, a publication of the European Society of Cardiology, demonstrates the ...

"In the future, when ELISA shows an elevated cTnI level, your doctor might order a comprehensive nanoproteomics test to determine whether it is caused by heart disease or not, and identify different ...

A surge of cardiac troponins appeared to be the norm even after uneventful coronary artery bypass graft (CABG) surgery, a prospective study confirmed, and how high these biomarkers go depended on the ...

(HealthDay)—Even very low concentrations of high-sensitivity cardiac troponin I (hs-cTnI) cannot safely rule out inducible myocardial ischemia in patients with symptomatic coronary artery disease (CAD ...

ALAMEDA, Calif., Nov. 1, 2017 /PRNewswire/ -- Singulex, a global immunodiagnostics company pioneering ultra-sensitivity in the precision measurement of biomarkers, today announced it has filed a 510(k ...

To enhance care delivery in emergency departments (EDs) through faster risk-stratification methods, this webinar will showcase initial findings from the ICare-FASTER interventional clinical trial.